AF Ablation in Patients With Hypertrophic Cardiomyopathy AF Ablation in Patients With Hypertrophic Cardiomyopathy
A new study finds modest success rates for catheter ablation for AF in patients with hypertrophic cardiomyopathy, but this commentary points out several caveats to consider.Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 12, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Hypertrophic Cardiomyopathy Risk Stratification Hypertrophic Cardiomyopathy Risk Stratification
Current and novel markers show promise for better accuracy of risk assessment for sudden cardiac death in patients with this condition.American College of Cardiology & Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 5, 2021 Category: Cardiology Tags: Cardiology Commentary Source Type: news

Peripartum Cardiomyopathy: From Genetics to Management Peripartum Cardiomyopathy: From Genetics to Management
Review our current understanding of the role of genetics in peripartum cardiomyopathy, a potentially life-threatening complication of pregnancy. What is the best approach to diagnosis and management?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Dilated cardiomyopathy associated with paraquat herbicide poisoning - Ahmad J, D'Angelo K, Rivas M, Mahal M, Nookala V, Kulakauskiene D, Makaryus AN.
Dilated cardiomyopathy is a subset of cardiomyopathies defined by reduced ejection fraction of less than 45% and a dilated left ventricle. While dilated cardiomyopathy is common, its etiology is not always readily evident. Paraquat is used as an herbicide ... (Source: SafetyLit)
Source: SafetyLit - September 27, 2021 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

Reflections on Hypertrophic Cardiomyopathy Reflections on Hypertrophic Cardiomyopathy
A physician reflects on his career and the advances that have occurred in our understanding of hypertrophic cardiomyopathy in the 63 years since diagnosing his first patients with this condition.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 22, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Another Agent Raises Hopes for Obstructive HCM in Early Study Another Agent Raises Hopes for Obstructive HCM in Early Study
Hemodynamics improved significantly for patients with obstructive hypertrophic cardiomyopathy who took aficamten, the second myosin inhibitor to reach clinical trials, in a small randomized study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 13, 2021 Category: Consumer Health News Tags: Cardiology News Source Type: news

PAUSE-SCD Strengthens Case for First-line VT Ablation Before ICD PAUSE-SCD Strengthens Case for First-line VT Ablation Before ICD
In the first VT-ablation trial of its kind in Asia and the first to offer insights for nonischemic cardiomyopathy, VT suppression and survival were superior when ablation preceded ICD implantation.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 16, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

' Abandoned' Man Dies in Hospital Waiting Room, Lawsuit Says'Abandoned' Man Dies in Hospital Waiting Room, Lawsuit Says
The 596-bed WellSpan York Hospital in Pennsylvania later determined that Terry Odoms, a 72-year-old Marine Corps and Vietnam veteran, died of ischemic cardiomyopathy.Associated Press (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - August 6, 2021 Category: Intensive Care Tags: Emergency Medicine News Source Type: news

Managing Hypertrophic Cardiomyopathy: New Guidelines and Drugs Managing Hypertrophic Cardiomyopathy: New Guidelines and Drugs
Cardiologist Christopher DeSimone speaks with Steve Ommen about new AHA/ACC guidelines, emerging treatments, and the importance of focused HCM care.Mayo Clinic (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 2, 2021 Category: Cardiology Tags: Cardiology Commentary Source Type: news

Lawn mower versus left ventricular assist device: a case of traumatic coronary injury - Rao VN, Fudim M, Griffin A, Rymer JA, Jones WS, Koweek LMH, Smith TP, Marin D, DeVore AD.
A 77-year-old man with history of ischemic cardiomyopathy and left ventricular assist device (LVAD) presented with  abdominal pain after a lawn mower accident. Examination and imaging revealed a displaced LVAD driveline and a pericardial hematoma secondar... (Source: SafetyLit)
Source: SafetyLit - July 30, 2021 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Study IDs risk factors for irregular heartbeats in hypertrophic cardiomyopathy patients
(University of Virginia Health System) The new research will help doctors identify, treat and prevent dangerous atrial fibrillation in patients with hypertrophic cardiomyopathy, a common heart condition. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 15, 2021 Category: International Medicine & Public Health Source Type: news

Methamphetamine-Linked Heart Failure Up in California
WEDNESDAY, July 14, 2021 -- From 2008 to 2018, there was a sharp increase in methamphetamine-associated cardiomyopathy/heart failure (MethHF) hospitalizations and related costs in California, according to a study published online July 14 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2021 Category: Pharmaceuticals Source Type: news

Teen, Parent Response Explored for Cardiomyopathy Genetic Tests
TUESDAY, July 13, 2021 -- Parents with unaffected children and positive predictive cardiomyopathy genetic testing results are more likely to experience negative emotions about the results, but they have better family functioning scores, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2021 Category: Pharmaceuticals Source Type: news

Personalized medicine for cats with heart disease
(University of California - Davis) Veterinarians at the University of California, Davis, have found that a cat's DNA alters how it responds to a life-saving medication used to treat hypertrophic cardiomyopathy, or HCM, a heart disease that affects 1 in 7 cats. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 6, 2021 Category: International Medicine & Public Health Source Type: news

Genome-wide Association for HF: From Discovery to Clinical Use Genome-wide Association for HF: From Discovery to Clinical Use
A new GWAS study has identified a a polygenic risk score that contributes to dilated cardiomyopathy, opening the door to clinical use of these scores for determining HF or DCM progression.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 23, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news